Literature DB >> 24702540

The Quality Function Measure: reliability and discriminant validity of a new measure of quality of gross motor movement in ambulatory children with cerebral palsy.

F Virginia Wright1, Peter Rosenbaum, Darcy Fehlings, Ronit Mesterman, Ute Breuer, Marie Kim.   

Abstract

AIM: Optimizing movement quality is a common rehabilitation goal for children with cerebral palsy (CP). The new Quality Function Measure (QFM)--a revision of the Gross Motor Performance Measure (GMPM)--evaluates five attributes: Alignment, Co-ordination, Dissociated movement, Stability, and Weight-shift, for the Gross Motor Function Measure (GMFM) Stand and Walk/Run/Jump items. This study evaluated the reliability and discriminant validity of the QFM.
METHOD: Thirty-three children with CP (17 females, 16 males; mean age 8y 11mo, SD 3y 1mo; Gross Motor Function Classification System [GMFCS] levels I [n=17], II [n=7], III [n=9]) participated in reliability testing. Each did a GMFM Stand/Walk assessment, repeated 2 weeks later. Both GMFM assessments were videotaped. A physiotherapist assessor pair independently scored the QFM from an assigned child's GMFM video. GMFM data from 112 children. That is, (GMFCS I [n=38], II [n=27], III [n=47]) were used for discriminant validity evaluation.
RESULTS: QFM mean scores varied from 45.0% (SD 27.2; Stability) to 56.2% (SD 27.5; Alignment). Reliability was excellent across all attributes: intraclass correlation coefficients (ICCs) ≥0.97 (95% confidence intervals [CI] 0.95-0.99), interrater ICCs ≥0.89 (95% CI 0.80-0.98), and test-retest ICCs ≥0.90 (95% CI 0.79-0.99). QFM discriminated qualitative attributes of motor function among GMFCS levels (maximum p<0.05).
INTERPRETATION: The QFM is reliable and valid, making it possible to assess how well young people with CP move and what areas of function to target to enhance quality of motor control.
© 2014 Mac Keith Press.

Entities:  

Mesh:

Year:  2014        PMID: 24702540     DOI: 10.1111/dmcn.12453

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  7 in total

1.  Exercise Prescription Improve the Rehabilitation of a Child With Viral Encephalitis Sequelae: A Case Report.

Authors:  Yang Wang; Xiaodong Kang; Jiao Jiao; Jihe Zhou; Bik-Chu Chow; Julien S Baker; Li Zhao; Siyu Liu
Journal:  Front Pediatr       Date:  2022-05-31       Impact factor: 3.569

2.  Interrater Reliability of the Observable Movement Quality Scale for Children.

Authors:  Lieke M A Dekkers; Maria W G Nijhuis-van der Sanden; Marianne Jonker; Bert J M de Swart; Anjo J W M Janssen
Journal:  Physiother Can       Date:  2018       Impact factor: 1.037

3.  Comparison of a robotic-assisted gait training program with a program of functional gait training for children with cerebral palsy: design and methods of a two group randomized controlled cross-over trial.

Authors:  Alicia J Hilderley; Darcy Fehlings; Gloria W Lee; F Virginia Wright
Journal:  Springerplus       Date:  2016-10-28

4.  Construct Validity of the Observable Movement Quality Scale in Pediatrics: Hypothesis Testing of a Formative Measurement Model.

Authors:  Lieke M A Dekkers; Anjo J W M Janssen; A Rogier T Donders; Maria W G Nijhuis-van der Sanden; Bert J M de Swart
Journal:  Phys Ther       Date:  2020-02-07

5.  Protocol for The Toxin Study: Understanding clinical and patient reported response of children and young people with cerebral palsy to intramuscular lower limb Botulinum neurotoxin-A injections, exploring all domains of the ICF. A pragmatic longitudinal observational study using a prospective one-group repeated measures design.

Authors:  Lesley R Katchburian; Kate Oulton; Eleanor Main; Christopher Morris; Lucinda J Carr
Journal:  BMJ Open       Date:  2021-04-21       Impact factor: 2.692

6.  Evaluation of the effectiveness of robotic gait training and gait-focused physical therapy programs for children and youth with cerebral palsy: a mixed methods RCT.

Authors:  Lesley Wiart; Rhonda J Rosychuk; F Virginia Wright
Journal:  BMC Neurol       Date:  2016-06-02       Impact factor: 2.474

7.  Potentiation of cord blood cell therapy with erythropoietin for children with CP: a 2 × 2 factorial randomized placebo-controlled trial.

Authors:  Kyunghoon Min; Mi Ri Suh; Kye Hee Cho; Wookyung Park; Myung Seo Kang; Su Jin Jang; Sang Heum Kim; Seonkyeong Rhie; Jee In Choi; Hyun-Jin Kim; Kwang Yul Cha; MinYoung Kim
Journal:  Stem Cell Res Ther       Date:  2020-11-27       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.